Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jean-Marc Limacher

Showing results (11-20 of 43) with videos related to

Pageof 5
Sort By:
Cancer Genetics and Cytogenetics|April 12, 2002
Gastrointestinal stromal tumor in an XYY/XY maleJean-Marc Limacher, Françoise Girard-Lemaire, Eric Jeandidier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanomaReinhard Dummer, Christoph Rochlitz, Thierry Velu, et al.
Journal for Immunotherapy of Cancer|September 20, 2017
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLCCaroline Tosch, Bérangère Bastien, Luc Barraud, et al.
Hepato-Gastroenterology|May 17, 2003
A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancerJean-Emmanuel Kurtz, Sylvie Négrier, Fares Husseini, et al.
Journal of Translational Medicine|September 26, 2013
Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042Nathalie Accart, Mirjana Urosevic-Maiwald, Reinhard Dummer, et al.
Oncoimmunology|August 7, 2014
Trial Watch:: Oncolytic viruses for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.
Clinical Breast Cancer|November 22, 2022
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 OutbreakSophie Martin, Carole Pflumio, Philippe Trensz, et al.
Breast Cancer (Tokyo, Japan)|June 16, 2026
BRCA pathogenic variants and response in early TNBC patients treated with neoadjuvant pembrolizumab: outcomes of the BRCAPATH studyBogdan-Valentin Popescu, Lucie Simon, Céline Blaye, et al.
BMC Medical Genetics|September 24, 2011
An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predispositionDanièle Muller, Etienne Rouleau, Inès Schultz, et al.
Gynecologic Oncology|April 9, 2019
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-upDiane M Harper, Pekka Nieminen, Gilbert Donders, et al.
Pageof 5

Showing results (11-20 of 43) with videos related to

Sort By:
Pageof 5
Cancer Genetics and Cytogenetics|April 12, 2002
Gastrointestinal stromal tumor in an XYY/XY maleJean-Marc Limacher, Françoise Girard-Lemaire, Eric Jeandidier, et al.
Molecular Therapy : the Journal of the American Society of Gene Therapy|April 5, 2008
Intralesional adenovirus-mediated interleukin-2 gene transfer for advanced solid cancers and melanomaReinhard Dummer, Christoph Rochlitz, Thierry Velu, et al.
Journal for Immunotherapy of Cancer|September 20, 2017
Viral based vaccine TG4010 induces broadening of specific immune response and improves outcome in advanced NSCLCCaroline Tosch, Bérangère Bastien, Luc Barraud, et al.
Hepato-Gastroenterology|May 17, 2003
A phase II study of docetaxel-irinotecan combination in advanced pancreatic cancerJean-Emmanuel Kurtz, Sylvie Négrier, Fares Husseini, et al.
Journal of Translational Medicine|September 26, 2013
Lymphocytic infiltration in the cutaneous lymphoma microenvironment after injection of TG1042Nathalie Accart, Mirjana Urosevic-Maiwald, Reinhard Dummer, et al.
Oncoimmunology|August 7, 2014
Trial Watch:: Oncolytic viruses for cancer therapyJonathan Pol, Norma Bloy, Florine Obrist, et al.
Clinical Breast Cancer|November 22, 2022
Consequences of Discontinuing a 4/6 Cyclin D-Dependent Kinase Inhibitor During Endocrine Treatment in Hormone-Sensitive Metastatic Breast Cancer Patients in the Context of the COVID-19 OutbreakSophie Martin, Carole Pflumio, Philippe Trensz, et al.
Breast Cancer (Tokyo, Japan)|June 16, 2026
BRCA pathogenic variants and response in early TNBC patients treated with neoadjuvant pembrolizumab: outcomes of the BRCAPATH studyBogdan-Valentin Popescu, Lucie Simon, Céline Blaye, et al.
BMC Medical Genetics|September 24, 2011
An entire exon 3 germ-line rearrangement in the BRCA2 gene: pathogenic relevance of exon 3 deletion in breast cancer predispositionDanièle Muller, Etienne Rouleau, Inès Schultz, et al.
Gynecologic Oncology|April 9, 2019
The efficacy and safety of Tipapkinogen Sovacivec therapeutic HPV vaccine in cervical intraepithelial neoplasia grades 2 and 3: Randomized controlled phase II trial with 2.5 years of follow-upDiane M Harper, Pekka Nieminen, Gilbert Donders, et al.
Pageof 5